Why the study?
Does transgenic overexpression of human ET-1 induce renal pathology and hypertension in mice?
Does transgenic overexpression of human ET-1 induce renal pathology and hypertension in mice?
Chronic activation of the paracrine endothelin system induces severe renal fibrosis and fatal kidney disease without causing hypertension, providing a new blood pressure-independent model of ET-1-induced renal pathology.
Answers are grounded in this paper and cite their sources.
Suggests ET-1 drives renal fibrosis independently of hypertension; extends preclinical models but leaves human translation open.
The human endothelin-1 (ET-1) gene under the control of its natural promoter was transferred into the germline of mice. The transgene was expressed predominantly in the brain, lung, and kidney. Transgene expression was associated with a pathological phenotype manifested by signs such as age-dependent development of renal cysts, interstitial fibrosis of the kidneys, and glomerulosclerosis leading to a progressive decrease in glomerular filtration rate. This pathology developed in spite of only slightly elevated plasma and tissue ET-1 concentrations. Blood pressure was not affected even after the development of an impaired glomerular filtration rate. Therefore, these transgenic lines provide a new blood pressure-independent animal model of ET-1-induced renal pathology leading to renal fibrosis and fatal kidney disease.
No takes yet. Share an insight, caveat, or question.
Hocher et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: